| Relationship of cortical atrophy to fatigue in patients with multiple sclerosis C Pellicano, A Gallo, X Li, VN Ikonomidou, IE Evangelou, JM Ohayon, ... Archives of neurology 67 (4), 447-453, 2010 | 186 | 2010 |
| Neuropharmacology and behavior in planarians: translations to mammals FR Buttarelli, C Pellicano, FE Pontieri Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology …, 2008 | 144 | 2008 |
| Prodromal non-motor symptoms of Parkinson’s disease C Pellicano, D Benincasa, V Pisani, FR Buttarelli, M Giovannelli, ... Neuropsychiatric disease and treatment 3 (1), 145-152, 2007 | 136 | 2007 |
| The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders F R Buttarelli, A Fanciulli, C Pellicano, F E Pontieri Current Neuropharmacology 9 (2), 278-288, 2011 | 116 | 2011 |
| Intensity-dependent facial emotion recognition and cognitive functions in Parkinson’s disease F Assogna, FE Pontieri, L Cravello, A Peppe, M Pierantozzi, A Stefani, ... Journal of the International Neuropsychological Society 16 (5), 867-876, 2010 | 77 | 2010 |
| Cortical thinning across Parkinson's disease stages and clinical correlates H Wilson, F Niccolini, C Pellicano, M Politis Journal of the Neurological Sciences 398, 31-38, 2019 | 72 | 2019 |
| Minocycline in amyotrophic lateral sclerosis: a pilot study FE Pontieri, A Ricci, C Pellicano, D Benincasa, FR Buttarelli Neurological Sciences 26, 285-287, 2005 | 63 | 2005 |
| Foot pressure wearable sensors for freezing of gait detection in Parkinson’s disease A Marcante, R Di Marco, G Gentile, C Pellicano, F Assogna, FE Pontieri, ... Sensors 21 (1), 128, 2020 | 62 | 2020 |
| Drug choices and advancements for managing depression in Parkinson's disease F Assogna, C Pellicano, C Savini, L Macchiusi, GR Pellicano, ... Current neuropharmacology 18 (4), 277-287, 2020 | 59 | 2020 |
| Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson׳ s disease FE Pontieri, F Assogna, C Pellicano, C Cacciari, S Pannunzi, A Morrone, ... European Neuropsychopharmacology 25 (1), 69-76, 2015 | 51 | 2015 |
| Morphometric changes in the reward system of Parkinson’s disease patients with impulse control disorders C Pellicano, F Niccolini, K Wu, SS O’Sullivan, AD Lawrence, AJ Lees, ... Journal of neurology 262, 2653-2661, 2015 | 50 | 2015 |
| Feasibility and utility of mHealth for the remote monitoring of Parkinson disease: ancillary study of the PD_manager randomized controlled trial D Gatsios, A Antonini, G Gentile, A Marcante, C Pellicano, L Macchiusi, ... JMIR mHealth and uHealth 8 (6), e16414, 2020 | 45 | 2020 |
| Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson’s disease from essential tremor C Pellicano, FR Buttarelli, A Circella, D Tiple, M Giovannelli, D Benincasa, ... Journal of neural transmission 114, 935-938, 2007 | 45 | 2007 |
| Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric … MD Orfei, F Assogna, C Pellicano, FE Pontieri, C Caltagirone, ... Parkinsonism & related disorders 54, 62-67, 2018 | 43 | 2018 |
| Neuropsychiatric and cognitive symptoms and body side of onset of parkinsonism in unmedicated Parkinson's disease patients C Pellicano, F Assogna, L Cravello, R Langella, C Caltagirone, ... Parkinsonism & Related Disorders 21 (9), 1096-1100, 2015 | 43 | 2015 |
| Regional cortical thickness and cognitive functions in non‐demented Parkinson’s disease patients: a pilot study C Pellicano, F Assogna, F Piras, C Caltagirone, FE Pontieri, G Spalletta European Journal of Neurology 19 (1), 172-175, 2012 | 37 | 2012 |
| T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis F Bagnato, Z Salman, R Kane, S Auh, FK Cantor, M Ehrmantraut, A Gallo, ... Multiple Sclerosis Journal 16 (10), 1203-1212, 2010 | 36 | 2010 |
| Central and peripheral dopamine transporter reduction in Parkinson's disease FR Buttarelli, G Capriotti, C Pellicano, D Prosperi, A Circella, A Festa, ... Neurological Research 31 (7), 687-691, 2009 | 35 | 2009 |
| Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease C Pellicano, F Assogna, N Cellupica, F Piras, M Pierantozzi, A Stefani, ... Parkinsonism & related disorders 45, 50-56, 2017 | 33 | 2017 |
| Management and treatment of patients with major depressive disorder and chronic diseases: A multidisciplinary approach SS Almeida, FB Zizzi, A Cattaneo, A Comandini, G Di Dato, E Lubrano, ... Frontiers in psychology 11, 542444, 2020 | 28 | 2020 |
Francesco E. Pontieri在 uniroma1.it 的电子邮件经过验证
